SPC525
Datopotamab deruxtecan
Status:
UmsóknApplication date:
9.9.2025Application published:
1.10.2025
Medicine name:
DatrowayMedicine for children:
No
Timeline
Today
9.9.2025Application
1.10.2025Publication
Marketing license
Foreign authorization number:
EU/1/25/1915Date:
4.4.2025
Owner
Name:
Daiichi Sankyo Company, LimitedAddress:
3-5-1, Nihonbashi Honcho Chuo-ku, Tokyo JP
Name:
Sapporo Medical UniversityAddress:
291-85, Minami 1-jo Nishi 17-chome Chuo-ku, Sapporo-shi, Hokkaido JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3088419